When it comes to research, getting GPs involved works
The role of aspirin in preventing cardiovascular events has been back in the news, following publication last year of three large clinical trials on the subject.
One of them was the ASPREE (Aspirin in Reducing Events in the Elderly) study. Its keenly awaited results confirmed the stance of Australian guideline developers that low-dose aspirin for primary prevention in healthy older patients is likely to do more harm than good.
In addition to these findings, the trial also demonstrated the increasing participation